162 related articles for article (PubMed ID: 3965572)
1. Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells.
Herlyn D; Powe J; Ross AH; Herlyn M; Koprowski H
J Immunol; 1985 Feb; 134(2):1300-4. PubMed ID: 3965572
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
Masui H; Moroyama T; Mendelsohn J
Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
[TBL] [Abstract][Full Text] [Related]
3. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
[TBL] [Abstract][Full Text] [Related]
4. Cell binding and tumor inhibiting functions of a new antihuman melanoma murine monoclonal antibody.
Abdel-Wahab Z; Darrow T; Vervaert CE; Crowley NJ; Seigler HF
Mol Biother; 1991 Sep; 3(3):163-9. PubMed ID: 1768367
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharide.
Steplewski Z; Lubeck MD; Scholz D; Loibner H; McDonald Smith J; Koprowski H
In Vivo; 1991; 5(2):79-83. PubMed ID: 1768791
[TBL] [Abstract][Full Text] [Related]
6. Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation model.
Vuist WM; v Buitenen F; de Rie MA; Hekman A; Rümke P; Melief CJ
Cancer Res; 1989 Jul; 49(14):3783-8. PubMed ID: 2472198
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model.
Hooijberg E; van den Berk PC; Sein JJ; Wijdenes J; Hart AA; de Boer RW; Melief CJ; Hekman A
Cancer Res; 1995 Feb; 55(4):840-6. PubMed ID: 7531616
[TBL] [Abstract][Full Text] [Related]
8. In vivo destruction of canine lymphoma mediated by murine monoclonal antibodies.
Steplewski Z; Rosales C; Jeglum KA; McDonald-Smith J
In Vivo; 1990; 4(4):231-4. PubMed ID: 2103365
[TBL] [Abstract][Full Text] [Related]
9. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
10. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
Sung C; Shockley TR; Morrison PF; Dvorak HF; Yarmush ML; Dedrick RL
Cancer Res; 1992 Jan; 52(2):377-84. PubMed ID: 1728409
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of tumor growth inhibition.
Steplewski Z; Herlyn D; Lubeck M; Kimoto Y; Herlyn M; Koprowski H
Hybridoma; 1986 Jul; 5 Suppl 1():S59-64. PubMed ID: 3744386
[No Abstract] [Full Text] [Related]
12. Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytes.
Barel M; Fiandino A; Delcayre AX; Lyamani F; Frade R
J Immunol; 1988 Sep; 141(5):1590-5. PubMed ID: 2842398
[TBL] [Abstract][Full Text] [Related]
13. Spatial distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Shockley TR; Lin K; Nagy JA; Tompkins RG; Yarmush ML; Dvorak HF
Cancer Res; 1992 Jan; 52(2):367-76. PubMed ID: 1728408
[TBL] [Abstract][Full Text] [Related]
14. Self-reactive antibody expression by human carcinoma cells engineered with monoclonal antibody genes.
Primus FJ; Finch MD; Masci AM; Schlom J; Kashmiri SV
Cancer Res; 1993 Jul; 53(14):3355-61. PubMed ID: 8324746
[TBL] [Abstract][Full Text] [Related]
15. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
16. Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects.
Rodeck U; Herlyn M; Herlyn D; Molthoff C; Atkinson B; Varello M; Steplewski Z; Koprowski H
Cancer Res; 1987 Jul; 47(14):3692-6. PubMed ID: 3297307
[TBL] [Abstract][Full Text] [Related]
17. Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice.
Hwang KM; Fodstad O; Oldham RK; Morgan AC
Cancer Res; 1985 Sep; 45(9):4150-5. PubMed ID: 4028007
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.
Herlyn D; Herlyn M; Steplewski Z; Koprowski H
Eur J Immunol; 1979 Aug; 9(8):657-9. PubMed ID: 499332
[TBL] [Abstract][Full Text] [Related]
19. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
Christiaansen JE; Sears DW
Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
[TBL] [Abstract][Full Text] [Related]
20. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]